ATRIX LABORATORIES INC 4
4 · ATRIX LABORATORIES INC · Filed Nov 8, 2004
Insider Transaction Report
Form 4
BETHUNE DAVID R
DirectorCEO/Chairman
Transactions
- Sale
Common Stock, $.001 Par Value
2004-11-05$31.01/sh−10,000$310,100→ 146,477 total - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-11-05$9.75/sh−10,000$97,500→ 60,000 totalExercise: $9.75From: 2001-06-02Exp: 2010-06-02→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock, $.001 Par Value
2004-11-05$9.75/sh+10,000$97,500→ 156,477 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.